Apraclonidine is an alpha-2 adrenergic agonist and sympathomimetic agent primarily utilized in the short-term management of intraocular hypertension to reduce aqueous humor production and delay or prevent… Read more








Apraclonidine is an alpha-2 adrenergic agonist and sympathomimetic agent primarily utilized in the short-term management of intraocular hypertension to reduce aqueous humor production and delay or prevent the need for glaucoma surgery. To ensure the safety and efficacy of this medication, pharmaceutical laboratories rely on high-quality analytical standards to support rigorous quality control and method validation protocols. This category provides access to critical reference materials, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope-labeled versions. These compounds, such as specific nitroso-related degradants, are essential for accurate impurity profiling and quantitative analysis throughout the drug development lifecycle. By utilizing these precise reference standards, researchers can perform reliable stability testing and method development, maintaining compliance with regulatory standards for ophthalmic therapeutic products.